Home › Kanser sa Esophagus
Pag-aaral pangklinika para sa Kanser sa Esophagus na nagre-recruit sa U.S.
110 pag-aaral para sa Kanser sa Esophagus ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX36 pag-aaral
- Boston, MA23 pag-aaral
- New York City, NY22 pag-aaral
- Nashville, TN19 pag-aaral
- St. Louis, MO17 pag-aaral
- Pittsburgh, PA15 pag-aaral
- Los Angeles, CA15 pag-aaral
- Grand Rapids, MI14 pag-aaral
- Baldwin Park, CA14 pag-aaral
- Philadelphia, PA13 pag-aaral
- San Antonio, TX12 pag-aaral
- Dallas, TX11 pag-aaral
- Chicago, IL11 pag-aaral
- Arlington, VA11 pag-aaral
- Rochester, MN11 pag-aaral
- San Diego, CA10 pag-aaral
- Durham, NC10 pag-aaral
- Cleveland, OH10 pag-aaral
- Portland, OR10 pag-aaral
- Washington, DC9 pag-aaral
- Atlanta, GA9 pag-aaral
- Denver, CO9 pag-aaral
- Detroit, MI9 pag-aaral
- Birmingham, AL8 pag-aaral
- Orlando, FL8 pag-aaral
- Milwaukee, WI8 pag-aaral
- Tampa, FL8 pag-aaral
- Minneapolis, MN8 pag-aaral
- Indianapolis, IN8 pag-aaral
- Toledo, OH7 pag-aaral
- Aurora, CO7 pag-aaral
- Edison, NJ7 pag-aaral
- Santa Monica, CA7 pag-aaral
- Seattle, WA7 pag-aaral
- Mountain View, CA7 pag-aaral
- Salt Lake City, UT7 pag-aaral
- Baltimore, MD7 pag-aaral
- Kansas City, MO7 pag-aaral
- Columbus, OH7 pag-aaral
- Queens, NY6 pag-aaral
Ayos sa estado
- Alabama8 pag-aaral
- Alaska4 pag-aaral
- Arizona11 pag-aaral
- Arkansas6 pag-aaral
- California41 pag-aaral
- Colorado19 pag-aaral
- Connecticut8 pag-aaral
- Delaware3 pag-aaral
- District of Columbia4 pag-aaral
- Florida33 pag-aaral
- Georgia11 pag-aaral
- Idaho3 pag-aaral
- Illinois15 pag-aaral
- Indiana12 pag-aaral
- Iowa6 pag-aaral
- Kansas8 pag-aaral
- Kentucky8 pag-aaral
- Louisiana5 pag-aaral
- Maine3 pag-aaral
- Maryland13 pag-aaral
- Massachusetts25 pag-aaral
- Michigan22 pag-aaral
- Minnesota19 pag-aaral
- Missouri20 pag-aaral
- Montana4 pag-aaral
- Nebraska7 pag-aaral
- New Jersey9 pag-aaral
- New Mexico6 pag-aaral
- New York28 pag-aaral
- North Carolina16 pag-aaral
- North Dakota4 pag-aaral
- Ohio22 pag-aaral
- Oklahoma8 pag-aaral
- Oregon11 pag-aaral
- Pennsylvania29 pag-aaral
- Rhode Island3 pag-aaral
- South Carolina7 pag-aaral
- South Dakota4 pag-aaral
- Tennessee21 pag-aaral
- Texas46 pag-aaral
- Utah8 pag-aaral
- Virginia16 pag-aaral
- Washington11 pag-aaral
- West Virginia3 pag-aaral
- Wisconsin16 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Nagre-recruitObservasyonal na pag-aaral
Edad 2 hanggang 120 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT00242723Distance-Based Exercise to Preserve Function and Prevent Disability
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07059884A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06465069Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07283939A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05319730Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06265285Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06760819A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06172478A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07090499A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07814248A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07578571Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07603375Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07519655DESTINY-PANTUMOUR04
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06123338Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379Pan-tumor MRD Study
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06605404sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05332002Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07114601A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07213791Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05983432Prehabilitation in High-risk Oncologic Surgery
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07638410Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07217704Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.